Presenter: Linda Jo Volness, MSN, APRN
Date Originally Presented: Wednesday, November 16, 2022
Time On Demand: Will be available until November 16, 2024
Summary:
Bipolar Disorder impacts the lives of children, adolescents and adults however there continues to be on average 10 years of misdiagnosis and nonbipolar treatment before receiving the diagnosis of bipolar disorder therefore delaying evidenced based pharmacological treatment. In most recent years there has been FDA approval of medications to treat different phases of bipolar illness. This presentation will describe both FDA and non FDA approved medications for the treatment of pediatric and adult individuals diagnosed with bipolar I or II disorder.
Contact Hours:This nursing continuing professional development activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Centers' Commission on Accreditation (OBN-001-91). Activity number 2022-0000000709
Criteria for Successful Completion
To obtain contact hour(s), one must attend the entire webinar and complete a post-webinar evaluation.
Conflict of Interest
No one with the ability to control content of this activity has a relevant financial relationship with an ineligible company.
Cost:
To Register: https://www.ispn-psych.org/treatment_options_bipolar_disorders
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
| Quantity | Price per voucher |
|---|---|
| 1+ | $0.00 |